Ledger.Open graph →
SEC Form D · filed May 15, 2025

Antares Therapeutics, Inc

Offering
$136.7M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Brian Piper · Boston, MAExecAdam Friedman · Boston, MAExec · DirectorAndrew Fedder · Boston, MAExecBrian Piper · Boston, MAExecAdam Friedman · Boston, MAExec · DirectorAndrew Fedder · Boston, MAExecMenelas N. Pangalos · Boston, MADirectorJeffrey Albers · Cambridge, MADirectorKeith Flaherty · Boulder, CODirectorJean-Francois Formela · Broomfield, CODirectorShelley Chu · San Diego, CADirectorHiroaki Kobayashi · BALTIMORE, MDExecJeffrey Cleland · BALTIMORE, MDExec · DirectorAkihiro Ko · BALTIMORE, MDExecMenelas N. Pangalos · Boston, MADirectorJeffrey Albers · Cambridge, MADirectorKeith Flaherty · Pembroke, MADirectorJean-Francois Formela · Cambridge, MADirectorShelley Chu · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗